% IMPORTANT: The following is UTF-8 encoded. This means that in the presence % of non-ASCII characters, it will not work with BibTeX 0.99 or older. % Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or % “biber”. @ARTICLE{Heneka:137851, author = {Heneka, Michael and Carson, Monica J and El Khoury, Joseph and Landreth, Gary E and Brosseron, Frederic and Feinstein, Douglas L and Jacobs, Andreas H and Wyss-Coray, Tony and Vitorica, Javier and Ransohoff, Richard M and Herrup, Karl and Frautschy, Sally A and Finsen, Bente and Brown, Guy C and Verkhratsky, Alexei and Yamanaka, Koji and Koistinaho, Jari and Latz, Eicke and Halle, Annett and Petzold, Gabor C and Town, Terrence and Morgan, Dave and Shinohara, Mari L and Perry, V Hugh and Holmes, Clive and Bazan, Nicolas G and Brooks, David J and Hunot, Stéphane and Joseph, Bertrand and Deigendesch, Nikolaus and Garaschuk, Olga and Boddeke, Erik and Dinarello, Charles A and Breitner, John C and Cole, Greg M and Golenbock, Douglas T and Kummer, Markus P}, title = {{N}euroinflammation in {A}lzheimer's disease.}, journal = {The lancet / Neurology}, volume = {14}, number = {4}, issn = {1474-4422}, address = {London}, publisher = {Lancet Publ. Group}, reportid = {DZNE-2020-04173}, pages = {388-405}, year = {2015}, abstract = {Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment, but includes strong interactions with immunological mechanisms in the brain. Misfolded and aggregated proteins bind to pattern recognition receptors on microglia and astroglia, and trigger an innate immune response characterised by release of inflammatory mediators, which contribute to disease progression and severity. Genome-wide analysis suggests that several genes that increase the risk for sporadic Alzheimer's disease encode factors that regulate glial clearance of misfolded proteins and the inflammatory reaction. External factors, including systemic inflammation and obesity, are likely to interfere with immunological processes of the brain and further promote disease progression. Modulation of risk factors and targeting of these immune mechanisms could lead to future therapeutic or preventive strategies for Alzheimer's disease.}, subtyp = {Review Article}, keywords = {Alzheimer Disease: genetics / Alzheimer Disease: immunology / Alzheimer Disease: metabolism / Alzheimer Disease: pathology / Alzheimer Disease: prevention $\&$ control / Animals / Anti-Inflammatory Agents, Non-Steroidal: therapeutic use / Astrocytes: immunology / Astrocytes: pathology / Biomarkers: blood / Biomarkers: cerebrospinal fluid / Brain Injuries: complications / Brain Injuries: metabolism / Clinical Trials as Topic / Disease Models, Animal / Disease Progression / Humans / Immunity, Innate / Immunization / Inflammation: diagnosis / Inflammation: immunology / Inflammation: metabolism / Inflammation Mediators: immunology / Inflammation Mediators: metabolism / Locus Coeruleus: pathology / Microglia: immunology / Microglia: pathology / Nootropic Agents: administration $\&$ dosage / Obesity: complications / Obesity: metabolism / Phagocytosis / Protein Folding / Risk Factors / Severity of Illness Index / Anti-Inflammatory Agents, Non-Steroidal (NLM Chemicals) / Biomarkers (NLM Chemicals) / Inflammation Mediators (NLM Chemicals) / Nootropic Agents (NLM Chemicals)}, cin = {AG Heneka ; AG Heneka / AG Latz ; AG Latz / AG Petzold ; AG Petzold}, ddc = {610}, cid = {I:(DE-2719)1011303 / I:(DE-2719)1013024 / I:(DE-2719)1013020}, pnm = {342 - Disease Mechanisms and Model Systems (POF3-342) / 344 - Clinical and Health Care Research (POF3-344)}, pid = {G:(DE-HGF)POF3-342 / G:(DE-HGF)POF3-344}, typ = {PUB:(DE-HGF)16}, pubmed = {pmid:25792098}, pmc = {pmc:PMC5909703}, doi = {10.1016/S1474-4422(15)70016-5}, url = {https://pub.dzne.de/record/137851}, }